Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine
dc.contributor.author | Pratz, Keith W. | |
dc.contributor.author | Jonas, Brian A. | |
dc.contributor.author | Pullarkat, Vinod | |
dc.contributor.author | Recher, Christian | |
dc.contributor.author | Schuh, Andre C. | |
dc.contributor.author | Thirman, Michael J. | |
dc.contributor.author | Garcia, Jacqueline S. | |
dc.contributor.author | DiNardo, Courtney D. | |
dc.contributor.author | Vorobyev, Vladimir | |
dc.contributor.author | Fracchiolla, Nicola S. | |
dc.contributor.author | Yeh, Su-Peng | |
dc.contributor.author | Jang, Jun Ho | |
dc.contributor.author | Ozcan, Muhit | |
dc.contributor.author | Yamamoto, Kazuhito | |
dc.contributor.author | Illés, Árpád | |
dc.contributor.author | Zhou, Ying | |
dc.contributor.author | Dail, Monique | |
dc.contributor.author | Chyla, Brenda | |
dc.contributor.author | Potluri, Jalaja | |
dc.contributor.author | Döhner, Hartmut | |
dc.date.accessioned | 2022-02-22T11:18:51Z | |
dc.date.available | 2022-02-22T11:18:51Z | |
dc.date.issued | 2022 | |
dc.date.oa | 2022-02-22 | |
dc.date.pasync | 2022-11-15T11:44:02Z | |
dc.date.updated | 2022-03-23T01:30:20Z | |
dc.description.corrector | LB | |
dc.identifier.citation | Journal Of Clinical Oncology. -40 : 8 (2022), p. 855-865. -J. Clin. Oncol. - 0732-183X. - 1527-7755 | |
dc.identifier.doi | http://dx.doi.org/10.1200/JCO.21.01546 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM100442 | |
dc.identifier.scopus | 85125966990 | |
dc.identifier.uri | http://hdl.handle.net/2437/328773 | |
dc.identifier.url | https://ascopubs.org/doi/10.1200/JCO.21.01546 | |
dc.identifier.wos | 000765922300008 | |
dc.language | eng | |
dc.rights.access | open access article | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Klinikai orvostudományok | |
dc.title | Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- jco.21.01546.pdf
- Méret:
- 522.55 KB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- Kiadói változat